CN101851637B - Method for preparing transgenic animal for expressing multiple genes simultaneously - Google Patents

Method for preparing transgenic animal for expressing multiple genes simultaneously Download PDF

Info

Publication number
CN101851637B
CN101851637B CN2010100343183A CN201010034318A CN101851637B CN 101851637 B CN101851637 B CN 101851637B CN 2010100343183 A CN2010100343183 A CN 2010100343183A CN 201010034318 A CN201010034318 A CN 201010034318A CN 101851637 B CN101851637 B CN 101851637B
Authority
CN
China
Prior art keywords
sequence
transgenic
gene
appa
embryo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2010100343183A
Other languages
Chinese (zh)
Other versions
CN101851637A (en
Inventor
李奎
鞠辉明
樊俊华
白立景
牟玉莲
杨述林
唐中林
崔文涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Animal Science of CAAS
Original Assignee
Institute of Animal Science of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Animal Science of CAAS filed Critical Institute of Animal Science of CAAS
Priority to CN2010100343183A priority Critical patent/CN101851637B/en
Priority to PCT/CN2010/000943 priority patent/WO2011085528A1/en
Priority to US13/122,399 priority patent/US8742085B2/en
Publication of CN101851637A publication Critical patent/CN101851637A/en
Application granted granted Critical
Publication of CN101851637B publication Critical patent/CN101851637B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/108Swine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/02Animal zootechnically ameliorated

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a method for preparing a transgenic animal for expressing a plurality of genes simultaneously. The invention also discloses a method for preparing a transgenic embryo. In the method for preparing the transgenic embryo, the transgenic embryo is obtained by transferring both a phytase gene and a human myxovirus resistance gene A into a target embryo. The transgenic animal for expressing the plurality of the genes can be obtained by transplanting the transgenic embryo into a female target animal. The method has the remarkable advantage that the plurality of the genes are expressed simultaneously by primary transgenosis and provides a convenient means for preparing a transferred united gene animal and the like.

Description

The method of the transgenic animal of a plurality of genes is expressed in a kind of preparation simultaneously
Technical field
The present invention relates to biological technical field, the method for the transgenic animal of a plurality of genes is expressed in particularly a kind of preparation simultaneously.
Background technology
In the research of traditional preparation process transgenic animal, often realize by carrier for expression of eukaryon, by molecular biology method target gene fragment is connected to the eukaryotic promoter downstream, can instruct exogenous gene expression after being incorporated in the cellular genome, this method has in the research of genetic expression and function extremely widely to be used, the each transgenosis of tradition transgenic method is only integrated a goal gene, and then the transgenic animal of a gene are expressed in preparation, if relate to preparation polygene transgenic animal, then need the corresponding single-gene transgenic animal of preparation separately, change the offspring of polygene animal then by the preparation of the methods such as mating between transgenic animal, this method for preparing the polygene animal wastes time and energy and expends height.
Summary of the invention
The object of the present invention is to provide a kind of method for preparing transgenic embryos.
The method for preparing transgenic embryos provided by the invention is that phytase gene and people myxovirus resistant gene A are all imported among the purpose embryo, obtains transgenic embryos.
Sequence 1 holds the 1360-2658 position from 5 ' in the nucleotide sequence of above-mentioned phytase gene such as the sequence table; Sequence 1 holds the 3803-5791 position from 5 ' in the nucleotide sequence of above-mentioned people myxovirus resistant gene A such as the sequence table.
Above-mentioned phytase gene and people myxovirus resistant gene A import among the embryo by the dna fragmentation of nucleotide sequence shown in sequence in the sequence table 1.
Above-mentioned embryo is a pronuclear-stage embryos.
Above-mentioned embryo specifically can be the embryo of pig, ox, sheep, cat, dog, rabbit or mouse for the embryo of any animal except that the people.
Another purpose of the present invention is to provide a kind of method of cultivating transgenic animal.
The method of cultivation transgenic animal provided by the invention is that the transgenic embryos that the above-mentioned method for preparing transgenic embryos is prepared is transplanted in the body of female purpose animal, obtains expressing simultaneously the transgenic animal of a plurality of genes.
The above-mentioned purpose animal can be any animal except that the people, specifically can be pig, ox, sheep, cat, dog, rabbit or mouse.
The carrier for expression of eukaryon pcDNA-appA-MxA of Expressing Recombinant Phytase and people myxovirus resistant gene when the present invention utilizes structure utilizes microinjection to prepare to contain the transgenic pig of dual-gene (phytase gene (appA) and people myxovirus resistant gene A (MxA)).Can detect the transgenic pig kind simultaneously and integrate dual-gene carrier significant advantage of the present invention simultaneously and show that transgenosis realizes polygenicly expressing simultaneously, changeing associating genetic animal etc. for preparation provides a kind of means easily.
Description of drawings
Fig. 1: amplification appA gel electrophoresis figure.
Fig. 2: pcDNA-appA plasmid map.
Fig. 3: amplification MxA gel electrophoresis figure.
Fig. 4: pcDNA-MxA plasmid map.
Fig. 5: pcDNA-appA-MxA plasmid map.
Fig. 6: the expression of embryo's detection by quantitative appA and MxA behind the microinjection AMP gene.
Fig. 7: AMP transgenic pig PCR detects foreign gene.
Fig. 8: AMP transgenic pig SOUTHERN BLOT detects foreign gene.
The expression of Fig. 9: detection by quantitative appA and MxA.
Embodiment
The invention will be further described below in conjunction with specific embodiment, but the present invention is not limited to following examples.
Among the following embodiment, if no special instructions, be ordinary method.
The preparation of embodiment 1, transgenic embryos
One, the structure of recombinant expression vector
Embodiment 1, express the structure of dual-gene carrier
1, the acquisition of single-gene expression vector basic building block
(1) preparation of carrier for expression of eukaryon pcDNA-appA is a template with bacillus coli DH 5 alpha (available from the full formula in Beijing King Company, article No. CD201), with primer amplification phytase gene (appA) fragment of the amplification appA that enumerates in the table 1.Reaction system is that reaction system is 50 μ l, 5 μ L, 10 * Buffer, 8 μ L 2.5mM dNTP, 1 μ L, 20 μ M primer appA-L1,1 μ L, 20 μ M primer appA-R1 (primer sequence sees Table 1), 0.5 μ L5U/ μ L high-fidelity Tag polysaccharase, 2 μ l bacillus coli DH 5s
α does template, adds ultrapure water to 50 μ L (the high-fidelity enzyme is precious biological available from Dalian, article No. DR010A).The pcr amplification program: 98 ℃ of 10s, 68 ℃ of 2min circulate 30 times.Pcr amplification product detects (as shown in Figure 1) with 1% agarose gel electrophoresis.
The PCR product reclaims purifying (operation steps is seen company's test kit) with QIAGEN sepharose test kit, with HindIII, EcoR I double digestion purified product; Use HindIII, EcoR I double digestion pcDNA3.1 (+) carrier (available from invitrogen company) simultaneously; Pcr amplification product is connected with carrier after enzyme is cut (ligase enzyme available from promega company, article No. M1804); Transform DH5 α (available from the full formula in Beijing King Company, article No. CD201) competence intestinal bacteria by company's requirement operation steps; Bacterium liquid is coated with agarose gel plate, overnight incubation in 37 ℃ of incubators; Choose single colony inoculation and cultivate in liquid LB substratum, part bacterium liquid send company's order-checking (invitrogen Beijing company); Choose sequencing result and show the carrier that contains appA (nucleotide sequence is held shown in the 1360-2658 position from 5 ' as sequence in the sequence table 1), it is standby to extract plasmid, and this order-checking is shown correct plasmid called after pcDNA-appA (plasmid map as shown in Figure 2).
(2) preparation of carrier for expression of eukaryon pcDNA-MxA
With people cDNA (extract stripped blood of the people extract total RNA, reverse transcription) is template, with primer amplification people myxovirus resistant gene A (MxA) fragment of the amplification MxA that enumerates in the table 1.Reaction system is that reaction system is 50 μ l, 5 μ L, 10 * Buffer, 8 μ L 2.5mM dNTP, 1 μ L, 20 μ M primer Mx-L1,1 μ L, 20 μ M primer Mx-R1 (sequence sees Table 1), 0.5 μ L5U/ μ L high-fidelity Tag polysaccharase, 100ng people cDNA is a template, add ultrapure water to 50 μ L (the high-fidelity enzyme is precious biological available from Dalian, article No. DR010A).The pcr amplification program: 98 ℃ of 10s, 68 ℃ of 2min,, circulate 30 times.Pcr amplification product detects (Fig. 3) with 1% agarose gel electrophoresis.
The PCR product reclaims purifying (operation steps is seen company's test kit) with QIAGEN sepharose test kit, with HindIII, EcoR I double digestion purified product; Use HindIII, EcoR I double digestion pcDNA3.1 (+) carrier (available from invitrogen company) simultaneously; Pcr amplification product is connected with carrier after enzyme is cut (ligase enzyme available from promega company, article No. M1804); Transform DH5 α (available from the full formula in Beijing King Company, article No. CD201) competence intestinal bacteria by company's requirement operation steps; Bacterium liquid is coated with agarose gel plate, overnight incubation in 37 ℃ of incubators; Choose single colony inoculation and cultivate in liquid LB substratum, part bacterium liquid send company's order-checking (invitrogen Beijing company); Choose sequencing result and show the carrier that contains MxA fragment (nucleotide sequence is held shown in the 3803-5791 position from 5 ' as sequence in the sequence table 1), the extraction plasmid is standby, and this order-checking is shown correct plasmid called after pcDNA-MxA (plasmid map as shown in Figure 4).
2, double gene expression vector AMP makes up
With above-mentioned pcDNA-appA (plasmid map as shown in Figure 2) is template, with the listed listed respective members of primer amplification table 1 of table 1.5 μ L, 10 * Buffer, 8 μ L 2.5mM dNTP, 1 μ L, 20 μ M primer CMV-appA-L1,1 μ L, 20 μ M primer CMVappA-R1 (sequence sees Table 1), 0.5 μ L5U/ μ L high-fidelity Tag polysaccharase, 100ng pcDNA-appA plasmid, add ultrapure water to 50 μ L (the high-fidelity enzyme is precious biological available from Dalian, article No. DR010A).The pcr amplification program: 98 ℃ of 10s, 68 ℃ of 3min circulate 30 times.Pcr amplification product detects with 1% agarose gel electrophoresis.PCR product partly check order (invitrogen company); Showing the CMV-appA-BGH pA fragment that amplification obtains (nucleotide sequence as sequence in the sequence table 1 from 5 ' end 618-2977 position shown in); CMV-appA-BGH pA fragment is by CMV promotor, appA and the BGH terminator of polyphone are formed successively; Wherein the CMV promotor (nucleotide sequence as sequence in the sequence table 1 from 5 ' end 671-1358 position shown in), appA (nucleotide sequence as sequence in the sequence table 1 from shown in 5 ' end 1360-2658 position) and BGH terminator (nucleotide sequence is shown in 5 of sequence in the sequence table 1 ' end 2735-2959 position).
Above-mentioned PCR product C MV-appA-BGH pA fragment reclaims purifying (operation steps is seen company's test kit) with QIAGEN sepharose test kit, cuts purified product with Mlu I enzyme; Use Mlu I single endonuclease digestion pcDNA-MxA plasmid simultaneously; Pcr amplification product is connected with carrier after enzyme is cut (ligase enzyme available from promega company, article No. M1804); Transform DH5 α (available from the full formula in Beijing King Company, article No. CD201) competence intestinal bacteria by company's requirement operation steps; Bacterium liquid is coated with agarose gel plate, overnight incubation in 37 ℃ of incubators.
Choosing single colony inoculation cultivates in liquid LB substratum, bacterium liquid PCR detects and inserts (the same amplification of the amplification system CMV-appA-BGH pA fragment part (primer sees Table 1) of CMV-appA-BGH pA fragment in the fragment, wherein template changes bacterium liquid 2 microlitres into), the result has corresponding CMV-appA-BGH pA fragment amplification band, send company's order-checking (invitrogen Beijing company) with the part bacterium liquid of above-mentioned difference; The result shows the recombinant expression vector that obtains to contain CMV-appA-BGH pA fragment and MxA expression cassette, with this carrier called after pcDNA-appA-MxA, abbreviates AMP as.The plasmid map of AMP as shown in Figure 5.
Order-checking shows that AMP has the nucleotide sequence of sequence 1 in the sequence table, contains appA expression cassette and MxA expression cassette in its sequence.
Wherein the appA expression cassette is made up of placed in-line CMV promotor successively (nucleotide sequence as sequence in the sequence table 1 from shown in 5 ' end 671-1358 position), appA (nucleotide sequence as sequence in the sequence table 1 from shown in 5 ' end 1360-2658 position) and BGH terminator (nucleotide sequence is shown in 5 of sequence in the sequence table 1 ' end 2735-2959 position); The MxA expression cassette is by placed in-line CMV promotor (nucleotide sequence is shown in 5 of sequence in the sequence table 1 ' end 3114-3802 position), MxA (nucleotide sequence is shown in 5 of sequence in the sequence table 1 ' end 3803-5791 position) and BGH terminator (nucleotide sequence is shown in 5 of sequence in the sequence table 1 ' end 5868-6092 position) are formed successively.
Two, the preparation of transgenic embryos
1, the pcDNA-appA-MxA that step 1 is obtained uses ScaI (available from fermentas company, article No. ER0431) and SmaI (available from fermentas company, article No. ER0661) band of agarose gel electrophoresis recovery 6.9Kb size behind the double digestion is diluted to 5ng/ μ l.Order-checking shows that the nucleotide sequence of the band of this 6.9Kb size is shown in sequence in the sequence table 1.
Utilize the method for microinjection to be expelled in the pronuclear-stage embryos of pig the linearizing fragment of above-mentioned 6.9Kb size, obtain transgenic embryos, (available from millipore company, article No. MR-182-D) is cultured to 8 cell stages in NCSU 23 substratum.
2, transgenic embryos detects
The genomic dna of getting part embryo wherein is directly as template, according to ProtoScript M-MuLV TaqRT-PCR test kit (available from NEB company, article No. E6400S) operation instructions (primer is the quantitative PCR detection primer of cited appA of table 1 and MxA), (primer is the appA-RTL1 in the table 1 directly to detect appA among the embryo
And appA-RTR1) and MxA (primer is hMx1-RTL1 and the hMx1-RTR1 in the table 1).The PCR reaction system is 50 μ l, 5 μ L10 * Buffer, 8 μ L2.5mM dNTP, 1 μ L20 μ M upstream primer, 1 μ L20 μ M downstream primer, 0.5 μ L5U/ μ L high-fidelity Tag polysaccharase, add ultrapure water to 50 μ L, piggy genomic dna with acquisition is a template to be detected, pcr amplification program: 95 ℃ of 5min; 94 ℃ of 20s, 56 ℃ of annealing temperatures, 72 ℃ of 1m circulate 30 times, and last 72 ℃ are extended 5min.Pcr amplification product detects with 1.0% agarose gel electrophoresis, filters out and can amplify appA, MxA gene respectively, and the result shows that among 24 embryos that detected, the 13rd and No. 17 embryo detects and can express appA gene and MxA gene (Fig. 6) simultaneously.
The preparation of embodiment 2, transgenic animal
One, preparation transgenic animal
Press the transgenic embryos of method preparation among the embodiment 1, ectogenesis will obtain 38 transgenic pigs through cultivating at the external sow horn of uterus of oestrusing synchronous of being transplanted to by the vagina uterine neck then to 8 cell stages.
Two, the integration of transgenic pig detects
1, PCR detects
The integration that utilizes appA and MxA detection by quantitative primer (seeing Table 1) to detect corresponding gene in the transgenic pig genomic dna detects the integration situation of foreign gene in the above-mentioned transgenic pig.
PCR reaction system and amplification system detect identical with the transgenic embryos of the step 2 of embodiment 1, filter out the pig (Fig. 7) that can amplify appA and MxA gene respectively (among the figure ,+: positive control, pcDNA-appA-Mx plasmid are template;-: negative control, normal pig DNA is a template; 1-23: be different transgenic progeny pig amplified bands).
From the last figure of Fig. 7 as seen: 3,6,11,17,20, No. 22 pig genomic dnas can amplify the band about 355bp in the 1-23 pig, and band is consistent with the appA band of expection amplification; 3,6,11,17,20, No. 22 pig genomic dnas can expand the 325bp band and expect that the MxA band of amplification is consistent in the pig from the visible 1-23 pig of figure below of Fig. 7.The amplified production order-checking shows that the segmental nucleotide sequence that amplifies is all correct.
2, southen hybridization detects
Quantitative PCR detection primer with appA in the table 1 and MxA is a primer respectively, according to test kit process specifications system application of sample; The PCR working procedure is as follows: 95 ℃ of 5min, and 94 ℃ of 45S, 56 ℃ of 1min, 72 ℃ of 1min, 30 circulations are extended 10min (the probe mark test kit are available from innogen-cn company, article No.: DDLK-010), obtain two PCR products for back 72 ℃.
Be that probe carries out southen hybridization and detects with above-mentioned two PCR products respectively, before the hybridization 95 ℃ of sex change place in the frozen water immediately after 5 minutes 10 minutes standby; The pig ear tissue DNA that is numbered 3,6,11,17,20, No. 22 transgenic pigs that identified in a large amount of extraction steps 1 with HindIII and Not I double digestion genome, concentrates the genome enzyme and cuts product to 300ng/ μ l; Separate each endonuclease bamhi in 1% agarose gel electrophoresis, sample 50 microlitres on every hole; Transfer on the positively charged nylon membrane after making the sex change of DNA original position then.Carry out prehybridization, hybridization and X-mating plate exposure tests hybridization signal (available from innogen-cn company, article No.: DIGD-210) according to the test kit operation instructions.Detected result (Fig. 8) shows that appA gene and MxA gene have been integrated in being numbered in 3,6,11,17,20, No. 22 transgenic pigs that southern hybridization detects.
Three, RT-PCR detects
The pig ear vein that is numbered 3,6,11,17,20, No. 22 transgenic pigs that sifts out from step 2 is respectively gathered 100 microliters of blood, according to sky root blood total RNA extraction reagent box (article No.: DP433) operation instructions, extract and respectively to organize cell total rna; According to TOYOBO reverse transcription test kit (article No.: FSK-100), total RNA reverse transcription of extracting is become cDNA.
Be template with above-mentioned cDNA respectively, with appA in the table 1 and MxA quantitative PCR detection primer, carry out sxemiquantitative PCR and detect appA and MxA, be confidential reference items (primer sees Table 1) wherein with pig GAPDH gene, the PCR reaction system is 50 μ l, 5 μ L10 * Buffer, 8 μ L 2.5mM dNTP, 1 μ L, 20 μ M upstream primers, 1 μ L, 20 μ M downstream primers (primer of amplification appA, MxA and pig GAPDH sees Table 1 respectively), 0.5 μ L5U/ μ L high-fidelity Tag polysaccharase, the 100ng template adds ultrapure water to 50 μ L.
Pcr amplification program: 95 ℃ of 5min; 94 ℃ of 20s, 56 ℃ of annealing temperatures, 72 ℃ of 1m,, last 72 ℃ are extended 5min, 23 circulations during confidential reference items GAPDH amplification, 32 circulations of other template amplifications.
Pcr amplification product detects (Fig. 9) with 1.2% agarose gel electrophoresis.Semi-quantitative results shows that 3, No. 20 pigs all can detect the expression of MxA and appA, illustrates that the transgenic pig of correspondence can be expressed MxA and appA gene simultaneously.
Table 1: the primer table 1 that is used for the amplification vector member among the present invention: the present invention is used for the primer of amplification vector member
Figure G2010100343183D00071
Sequence table
<110〉Institute of Animal Sciences, Chinese Academy of Agricultural Sciences
<120〉method of the transgenic animal of a plurality of genes is expressed in a kind of preparation simultaneously
<160>1
<210>1
<211>6915
<212>DNA
<213>1
<400>1
actcaaccaa?gtcattctga?gaatagtgta?tgcggcgacc?gagttgctct?tgcccggcgt 60
caatacggga?taataccgcg?ccacatagca?gaactttaaa?agtgctcatc?attggaaaac 120
gttcttcggg?gcgaaaactc?tcaaggatct?taccgctgtt?gagatccagt?tcgatgtaac 180
ccactcgtgc?acccaactga?tcttcagcat?cttttacttt?caccagcgtt?tctgggtgag 240
caaaaacagg?aaggcaaaat?gccgcaaaaa?agggaataag?ggcgacacgg?aaatgttgaa 300
tactcatact?cttccttttt?caatattatt?gaagcattta?tcagggttat?tgtctcatga 360
gcggatacat?atttgaatgt?atttagaaaa?ataaacaaat?aggggttccg?cgcacatttc 420
cccgaaaagt?gccacctgac?gtcgacggat?cgggagatct?cccgatcccc?tatggtgcac 480
tctcagtaca?atctgctctg?atgccgcata?gttaagccag?tatctgctcc?ctgcttgtgt 540
gttggaggtc?gctgagtagt?gcgcgagcaa?aatttaagct?acaacaaggc?aaggcttgac 600
cgacaattgc?atgaagaatc?tgcttagggt?taggcgtttt?gcgctgcttc?gcgatgtacg 660
ggccagatat?acgcgttgac?attgattatt?gactagttat?taatagtaat?caattacggg 720
gtcattagtt?catagcccat?atatggagtt?ccgcgttaca?taacttacgg?taaatggccc 780
gcctggctga?ccgcccaacg?acccccgccc?attgacgtca?ataatgacgt?atgttcccat 840
agtaacgcca?atagggactt?tccattgacg?tcaatgggtg?gagtatttac?ggtaaactgc 900
ccacttggca?gtacatcaag?tgtatcatat?gccaagtacg?ccccctattg?acgtcaatga 960
cggtaaatgg?cccgcctggc?attatgccca?gtacatgacc?ttatgggact?ttcctacttg 1020
gcagtacatc?tacgtattag?tcatcgctat?taccatggtg?atgcggtttt?ggcagtacat 1080
caatgggcgt?ggatagcggt?ttgactcacg?gggatttcca?agtctccacc?ccattgacgt 1140
caatgggagt?ttgttttggc?accaaaatca?acgggacttt?ccaaaatgtc?gtaacaactc 1200
cgccccattg?acgcaaatgg?gcggtaggcg?tgtacggtgg?gaggtctata?taagcagagc 1260
tctctggcta?actagagaac?ccactgctta?ctggcttatc?gaaattaata?cgactcacta 1320
tagggagacc?caagctggct?agcgtttaaa?cttaagctta?tgaaagcgat?cttaatccca 1380
tttttatctc?ttctgattcc?gttaaccccg?caatctgcat?tcgctcagag?tgagccggag 1440
ctgaagctgg?aaagtgtggt?gattgtcagt?cgtcatggtg?tgcgtgctcc?aaccaaggcc 1500
acgcaactga?tgcaggatgt?caccccagac?gcatggccaa?cctggccggt?aaaactgggt 1560
tggctgacac?cgcgcggtgg?tgagctaatc?gcctatctcg?gacattacca?acgccagcgt 1620
ctggtagccg?acggattgct?ggcgaaaaag?ggctgcccgc?agtctggtca?ggtcgcgatt 1680
attgctgatg?tcgacgagcg?tacccgtaaa?acaggcgaag?ccttcgccgc?cgggctggca 1740
cctgactgtg?caataaccgt?acatacccag?gcagatacgt?ccagtcccga?tccgttattt 1800
aatcctctaa?aaactggcgt?ttgccaactg?gataacgcga?acgtgactga?cgcgatcctc 1860
agcagggcag?gagggtcaat?tgctgacttt?accgggcatc?ggcaaacggc?gtttcgcgaa 1920
ctggaacggg?tgcttaattt?tccgcaatca?aacttgtgcc?ttaaacgtga?gaaacaggac 1980
gaaagctgtt?cattaacgca?ggcattacca?tcggaactca?aggtgagcgc?cgacaatgtc 2040
tcattaaccg?gtgcggtaag?cctcgcatca?atgctgacga?agatatttct?cctgcaacaa 2100
gcacagggaa?tgccggagcc?ggggtgggga?aggatcaccg?attcacacca?gtggaacacc 2160
ttgctaagtt?tgcataacgc?gcaattttat?ttgttacaac?gcacgccaga?ggttgcccgc 2220
agccgcgcca?ccccgttatt?agatttgatc?aagacagcgt?tgacgcccca?tccaccgcaa 2280
aaacaggcgt?atggtgtgac?attacccact?tcagtgctgt?ttatcgccgg?acacgatact 2340
aatctggcaa?atctcggcgg?cgcactggag?ctcaactgga?cgcttcccgg?tcagccggat 2400
aacacgccgc?caggtggtga?actggtgttt?gaacgctggc?gtcggctaag?cgataacagc 2460
cagtggattc?aggtttcgct?ggtcttccag?actttacagc?agatgcgtga?taaaacgccg 2520
ctgtcattaa?atacgccgcc?cggagaggtg?aaactgaccc?tggcaggatg?tgaagagcga 2580
aatgcgcagg?gcatgtgttc?gttggcaggt?tttacgcaaa?tcgtgaatga?agcacgcata 2640
ccggcgtgca?gtttgtaaga?attctgcaga?tatccagcac?agtggcggcc?gctcgagtct 2700
agagggcccg?tttaaacccg?ctgatcagcc?tcgactgtgc?cttctagttg?ccagccatct 2760
gttgtttgcc?cctcccccgt?gccttccttg?accctggaag?gtgccactcc?cactgtcctt 2820
tcctaataaa?atgaggaaat?tgcatcgcat?tgtctgagta?ggtgtcattc?tattctgggg 2880
ggtggggtgg?ggcaggacag?caagggggag?gattgggaag?acaatagcag?gcatgctggg 2940
gatgcggtgg?gctctatggc?ttctgaggcg?gaaagaacca?gctggggctc?tagggggtat 3000
ccccacgcgc?cctgtagcgg?cgcattaagc?gcggcgggtg?tggtggttac?gcgcagcgtg 3060
accgctacac?ttgccagcgc?cctagcgccc?gctcctttcg?ctttcttccc?ttcacgcgtt 3120
gacattgatt?attgactagt?tattaatagt?aatcaattac?ggggtcatta?gttcatagcc 3180
catatatgga?gttccgcgtt?acataactta?cggtaaatgg?cccgcctggc?tgaccgccca 3240
acgacccccg?cccattgacg?tcaataatga?cgtatgttcc?catagtaacg?ccaataggga 3300
ctttccattg?acgtcaatgg?gtggagtatt?tacggtaaac?tgcccacttg?gcagtacatc 3360
aagtgtatca?tatgccaagt?acgcccccta?ttgacgtcaa?tgacggtaaa?tggcccgcct 3420
ggcattatgc?ccagtacatg?accttatggg?actttcctac?ttggcagtac?atctacgtat 3480
tagtcatcgc?tattaccatg?gtgatgcggt?tttggcagta?catcaatggg?cgtggatagc 3540
ggtttgactc?acggggattt?ccaagtctcc?accccattga?cgtcaatggg?agtttgtttt 3600
ggcaccaaaa?tcaacgggac?tttccaaaat?gtcgtaacaa?ctccgcccca?ttgacgcaaa 3660
tgggcggtag?gcgtgtacgg?tgggaggtct?atataagcag?agctctctgg?ctaactagag 3720
aacccactgc?ttactggctt?atcgaaatta?atacgactca?ctatagggag?acccaagctg 3780
gctagcgttt?aaacttaagc?ttatggttgt?ttccgaagtg?gacatcgcaa?aagctgatcc 3840
agctgctgca?tcccaccctc?tattactgaa?tggagatgct?actgtggccc?agaaaaatcc 3900
aggctcggtg?gctgagaaca?acctgtgcag?ccagtatgag?gagaaggtgc?gcccctgcat 3960
cgacctcatt?gactccctgc?gggctctagg?tgtggagcag?gacctggccc?tgccagccat 4020
cgccgtcatc?ggggaccaga?gctcgggcaa?gagctccgtg?ttggaggcac?tgtcaggagt 4080
tgcccttccc?agaggcagcg?ggatcgtgac?cagatgcccg?ctggtgctga?aactgaagaa 4140
acttgtgaac?gaagataagt?ggagaggcaa?ggtcagttac?caggactacg?agattgagat 4200
ttcggatgct?tcagaggtag?aaaaggaaat?taataaagcc?cagaatgcca?tcgccgggga 4260
aggaatggga?atcagtcatg?agctaatcac?cctggagatc?agctcccgag?atgtcccgga 4320
tctgactcta?atagaccttc?ctggcataac?cagagtggct?gtgggcaatc?agcctgctga 4380
cattgggtat?aagatcaaga?cactcatcaa?gaagtacatc?cagaggcagg?agacaatcag 4440
cctggtggtg?gtccccagta?atgtggacat?tgccaccaca?gaggctctca?gcatggccca 4500
ggaggtggac?cccgagggag?acaggaccat?cggaatcttg?acgaagcctg?atctggtgga 4560
caaaggaact?gaagacaagg?ttgtggacgt?ggtgcggaac?ctcgtgttcc?acctgaagaa 4620
gggttacatg?attgtcaagt?gccggggcca?gcaggagatc?caggaccagc?tgagcctgtc 4680
cgaagccctg?cagagagaga?agatcttctt?tgagaaccac?ccatatttca?gggatctgct 4740
ggaggaagga?aaggccacgg?ttccctgcct?ggcagaaaaa?cttaccagcg?agctcatcac 4800
acatatctgt?aaatctctgc?ccctgttaga?aaatcaaatc?aaggagactc?accagagaat 4860
aacagaggag?ctacaaaagt?atggtgtcga?cataccggaa?gacgaaaatg?aaaaaatgtt 4920
cttcctgata?gataaaatta?atgcctttaa?tcaggacatc?actgctctca?tgcaaggaga 4980
ggaaactgta?ggggaggaag?acattcggct?gtttaccaga?ctccgacacg?agttccacaa 5040
atggagtaca?ataattgaaa?acaattttca?agaaggccat?aaaattttga?gtagaaaaat 5100
ccagaaattt?gaaaatcagt?atcgtggtag?agagctgcca?ggctttgtga?attacaggac 5160
atttgagaca?atcgtgaaac?agcaaatcaa?ggcactggaa?gagccggctg?tggatatgct 5220
acacaccgtg?acggatatgg?tccggcttgc?tttcacagat?gtttcgataa?aaaattttga 5280
agagtttttt?aacctccaca?gaaccgccaa?gtccaaaatt?gaagacatta?gagcagaaca 5340
agagagagaa?ggtgagaagc?tgatccgcct?ccacttccag?atggaacaga?ttgtctactg 5400
ccaggaccag?gtatacaggg?gtgcattgca?gaaggtcaga?gagaaggagc?tggaagaaga 5460
aaagaagaag?aaatcctggg?attttggggc?tttccaatcc?agctcggcaa?cagactcttc 5520
catggaggag?atctttcagc?acctgatggc?ctatcaccag?gaggccagca?agcgcatctc 5580
cagccacatc?cctttgatca?tccagttctt?catgctccag?acgtacggcc?agcagcttca 5640
gaaggccatg?ctgcagctcc?tgcaggacaa?ggacacctac?agctggctcc?tgaaggagcg 5700
gagcgacacc?agcgacaagc?ggaagttcct?gaaggagcgg?cttgcacggc?tgacgcaggc 5760
tcggcgccgg?cttgcccagt?tccccggtta?ggaattctgc?agatatccag?cacagtggcg 5820
gccgctcgag?tctagagggc?ccgtttaaac?ccgctgatca?gcctcgactg?tgccttctag 5880
ttgccagcca?tctgttgttt?gcccctcccc?cgtgccttcc?ttgaccctgg?aaggtgccac 5940
tcccactgtc?ctttcctaat?aaaatgagga?aattgcatcg?cattgtctga?gtaggtgtca 6000
ttctattctg?gggggtgggg?tggggcagga?cagcaagggg?gaggattggg?aagacaatag 6060
caggcatgct?ggggatgcgg?tgggctctat?ggcttctgag?gcggaaagaa?ccagctgggg 6120
ctctaggggg?tatccccacg?cgccctgtag?cggcgcatta?agcgcggcgg?gtgtggtggt 6180
tacgcgcagc?gtgaccgcta?cacttgccag?cgccctagcg?cccgctcctt?tcgctttctt 6240
cccttccttt?ctcgccacgt?tcgccggctt?tccccgtcaa?gctctaaatc?gggggctccc 6300
tttagggttc?cgatttagtg?ctttacggca?cctcgacccc?aaaaaacttg?attagggtga 6360
tggttcacgt?agtgggccat?cgccctgata?gacggttttt?cgccctttga?cgttggagtc 6420
cacgttcttt?aatagtggac?tcttgttcca?aactggaaca?acactcaacc?ctatctcggt 6480
ctattctttt?gatttataag?ggattttgcc?gatttcggcc?tattggttaa?aaaatgagct 6540
gatttaacaa?aaatttaacg?cgaattaatt?ctgtggaatg?tgtgtcagtt?agggtgtgga 6600
aagtccccag?gctccccagc?aggcagaagt?atgcaaagca?tgcatctcaa?ttagtcagca 6660
accaggtgtg?gaaagtcccc?aggctcccca?gcaggcagaa?gtatgcaaag?catgcatctc 6720
aattagtcag?caaccatagt?cccgccccta?actccgccca?tcccgcccct?aactccgccc 6780
agttccgccc?attctccgcc?ccatggctga?ctaatttttt?ttatttatgc?agaggccgag 6840
gccgcctctg?cctctgagct?attccagaag?tagtgaggag?gcttttttgg?aggcctaggc 6900
ttttgcaaaa?agctc 6915

Claims (4)

1. a method for preparing transgenic embryos is that phytase gene and people myxovirus resistant gene A are all imported among the purpose embryo, obtains transgenic embryos; Described embryo is the embryo of pig, ox, sheep, cat, dog, rabbit or mouse; Sequence 1 holds the 1360-2658 position from 5 ' in the nucleotide sequence of described phytase gene such as the sequence table; Sequence 1 holds the 3803-5791 position from 5 ' in the nucleotide sequence of described people myxovirus resistant gene A such as the sequence table; Described phytase gene and people myxovirus resistant gene A import among the embryo by the dna fragmentation of nucleotide sequence shown in sequence in the sequence table 1.
2. method according to claim 1 is characterized in that: described embryo is a pronuclear-stage embryos.
3. a method of cultivating transgenic animal is that the transgenic embryos of claim 1 or 2 described method preparations is transplanted in the body of female purpose animal, obtains expressing simultaneously the transgenic animal of a plurality of genes.
4. method according to claim 3 is characterized in that: described purpose animal is pig, ox, sheep, cat, dog, rabbit or mouse.
CN2010100343183A 2010-01-15 2010-01-15 Method for preparing transgenic animal for expressing multiple genes simultaneously Active CN101851637B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN2010100343183A CN101851637B (en) 2010-01-15 2010-01-15 Method for preparing transgenic animal for expressing multiple genes simultaneously
PCT/CN2010/000943 WO2011085528A1 (en) 2010-01-15 2010-06-24 Method for preparing transgenic animals simultaneously expressing multiple genes
US13/122,399 US8742085B2 (en) 2010-01-15 2010-06-24 Method for preparing a transgenic animal of simultaneous multiple-gene expression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010100343183A CN101851637B (en) 2010-01-15 2010-01-15 Method for preparing transgenic animal for expressing multiple genes simultaneously

Publications (2)

Publication Number Publication Date
CN101851637A CN101851637A (en) 2010-10-06
CN101851637B true CN101851637B (en) 2011-12-14

Family

ID=42803315

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010100343183A Active CN101851637B (en) 2010-01-15 2010-01-15 Method for preparing transgenic animal for expressing multiple genes simultaneously

Country Status (3)

Country Link
US (1) US8742085B2 (en)
CN (1) CN101851637B (en)
WO (1) WO2011085528A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110846337A (en) * 2019-11-26 2020-02-28 温氏食品集团股份有限公司 Multifunctional fusion enzyme XABT gene, and construction method and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63500800A (en) * 1985-07-31 1988-03-24 スタエリ,ピ−タ− Insertion of a gene encoding an interferon-induced protein into an animal
JPH07246040A (en) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd Germ stem cell having deactivated neurotrophin-3 gene and animal of manifestation incompetence of the same gene
US7115795B1 (en) * 1999-04-23 2006-10-03 University Of Guelph Transgenic animals expressing salivary proteins
AU4095800A (en) * 1999-04-23 2000-11-10 University Of Guelph Transgenic animals expressing salivary proteins
ES2156579B1 (en) * 2000-01-20 2002-01-16 Univ Murcia DEVICE AND METHOD FOR INTRODUCING AND / OR COLLECTING FLUIDS INSIDE THE UTERUS OF AN ANIMAL.
MXPA03001281A (en) * 2000-08-11 2003-06-30 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed.
DK1616012T3 (en) * 2003-04-24 2008-04-21 San Raffaele Centro Fond Lentiviral vectors bearing synthetic bidirectional promoters and their applications
WO2006037052A2 (en) * 2004-09-27 2006-04-06 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health Modulating mxa expression
WO2006063588A1 (en) * 2004-12-13 2006-06-22 Novozymes A/S Polypeptides having acid phosphatase activity and polynucleotides encoding same
CA2608481A1 (en) * 2005-05-14 2006-11-23 Fudan University Piggybac as a tool for genetic manipulation and analysis in vertebrates
CN101608189B (en) * 2009-07-17 2011-01-05 中国农业科学院北京畜牧兽医研究所 Eukaryotic expression carrier for expressing double genes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110846337A (en) * 2019-11-26 2020-02-28 温氏食品集团股份有限公司 Multifunctional fusion enzyme XABT gene, and construction method and application thereof
CN110846337B (en) * 2019-11-26 2023-02-28 温氏食品集团股份有限公司 Multifunctional fusion enzyme XABT gene, construction method and application

Also Published As

Publication number Publication date
CN101851637A (en) 2010-10-06
US20120233717A1 (en) 2012-09-13
US8742085B2 (en) 2014-06-03
WO2011085528A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
KR101320489B1 (en) Serum-free stable transfection and production of recombinant human proteins in human cell lines
KR101953237B1 (en) Novel dna-binding proteins and uses thereof
KR101828828B1 (en) Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
EP3158073B1 (en) Compositions and methods for making (s)-norcoclaurine and (s)-norlaudanosoline, and synthesis intermediates thereof
KR101921698B1 (en) Recombinantly produced human factor VIII and IX
CN107501405B (en) Autophagy inhibiting polypeptide
SG185920A1 (en) Dac hyp compositions and methods
EP3405484A1 (en) A method for producing insulin and insulin derivatives, and hybrid peptide used in this method
CN109021086B (en) Antibacterial peptide cecropin A mutant and encoding gene, preparation method and application thereof
CN101851637B (en) Method for preparing transgenic animal for expressing multiple genes simultaneously
CN113736763B (en) Myrosinase Rmmr and application thereof in preparation of sulforaphane and sulforaphane
KR20120059222A (en) Novel hybrid promoter and recombinant vector which includes the promoter
CN109134638B (en) House dust mite allergen Der p 22 gene recombinant protein and application thereof
Acker et al. Structure of the gene encoding the 14.5 kDa subunit of human RNA polymerase II
CN114395020B (en) Application of GmRALF1 protein in promoting phosphorus element absorption of plants
EP3344651B1 (en) A process for obtaining insulin with correctly formed disulfide bonds
CN101570760B (en) Recombinant mouse beta-alexin 3 polypeptide, preparation and use thereof
CN109369794B (en) Protein with function of regulating and controlling macrophage immune function activity
CN114207133A (en) Compositions and methods for treating DBA using GATA1 gene therapy
CN112342245B (en) CRISPR-Cas13d system for promoting suspension of CHO cells and recombinant CHO cells
US11401311B2 (en) Recombinant activin A precursor protein
EP2240511A2 (en) Compositions and methods for treating erectile dysfunction
CN107653244B (en) Hemostatic protein and preparation method and application thereof
KR20100125171A (en) Soluble myostatin prodomain recombination protein having myostatin inhibitory activity and its use
CN102153642B (en) Application of protein with function of inhibiting growth of scar fibroblast

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Li Kui

Inventor after: Ju Huiming

Inventor after: Fan Junhua

Inventor after: Bai Lijing

Inventor after: Mou Yulian

Inventor after: Yang Shulin

Inventor after: Tang Zhonglin

Inventor after: Cui Wentao

Inventor after: Zhou Rong

Inventor before: Li Kui

Inventor before: Ju Huiming

Inventor before: Fan Junhua

Inventor before: Bai Lijing

Inventor before: Mou Yulian

Inventor before: Yang Shulin

Inventor before: Tang Zhonglin

Inventor before: Cui Wentao

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LI KUI JU HUIMING FAN JUNHUA BAI LIJING MOU YULIAN YANG SHULIN TANG ZHONGLIN CUI WENTAO TO: LI KUI JU HUIMING FAN JUNHUA BAI LIJING MOU YULIAN YANG SHULIN TANG ZHONGLIN CUI WENTAO ZHOU RONG